BioMarin Pharmaceutical | BMRN - Eps Ganancias Por Acción

Precio De Mercado
57.07
Cambio Diario
-0.36 -0.63%
Mensual
-7.70%
Anual
-20.20%
Q1 Expectativa
56.74

Fiscal Calendario Real Consenso Anterior Fecha
FY2026Q1 Mar/2026 0.74 1.13 Apr/29 2026
FY2025Q4 Dec/2025 0.46 0.77 0.92 Feb/23 2026
FY2025Q3 Sep/2025 0.12 0.86 0.91 Oct/27 2025
FY2025Q2 Jun/2025 1.44 0.84 0.96 Aug/04 2025
FY2025Q1 Mar/2025 1.13 0.65 0.71 May/01 2025




Eps Cambio Fecha
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amgen USD 5.29 0.35 2025-12
Bayer EUR 0.62 0.05 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Incyte USD 1.8 0.46 2025-12
Insmed USD -1.54 0.21 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Moderna USD -2.11 1.6 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR -0.67 3.62 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12